首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Dopamine/serotonin receptor ligands. Part VIII((1)):the dopamine receptor antagonist LE300 - modelled and X-ray structure plus further pharmacological characterization, including serotonin receptor binding, biogenic amine transporter testing and in v
【24h】

Dopamine/serotonin receptor ligands. Part VIII((1)):the dopamine receptor antagonist LE300 - modelled and X-ray structure plus further pharmacological characterization, including serotonin receptor binding, biogenic amine transporter testing and in v

机译:多巴胺/ 5-羟色胺受体配体。第VIII((1)部分):多巴胺受体拮抗剂LE300-建模和X射线结构,以及进一步的药理学表征,包括血清素受体结合,生物胺转运蛋白测试和体内

获取原文
获取原文并翻译 | 示例
           

摘要

-LE300, a benz[d]indolo[2,3-g]azecine with nanomolar affinities to the hD(1) receptor family, has been further pharmacologically characterized and its modelled structure was compared to its X-ray structure in order to explain NMR data, that was not in accordance to the X-ray structure. Moderate affinity at the hD(3) receptor was determined, nanomolar affinities were found at the 5-HT(2A) and 5-HT(2C) receptors, micromolar affinity at the 5-HT(1A) receptor using binding assays. Functional studies indicate moderate antagonist activity at the 5-HT(2A) site. No activity was found at dopamine, serotonin and norepinephrine transporters. These results suggested the use of LE300 for cocaine addiction treatment. High activities were found using in vivo testing: LE300 suppressed spontanous locomotor activity with an ID(50) of 1.24 mg/kg and attenuated locomotor activity induced by 20 mg/kg cocaine with an AD(50) of 1.50 mg/kg. It failed to substitute for the discriminative stimulus effects produced by cocaine.
机译:-LE300是与hD(1)受体家族具有纳摩尔摩尔亲和力的苯并[d]吲哚并[2,3-g] a嗪,已在药理上作了进一步表征,并将其建模结构与X射线结构进行了比较,以说明NMR数据,与X射线结构不一致。确定了在hD(3)受体的适度亲和力,在5-HT(2A)和5-HT(2C)受体发现了纳摩尔亲和力,使用结合试验在5-HT(1A)受体发现了微摩尔亲和力。功能研究表明在5-HT(2A)站点适度的拮抗剂活性。在多巴胺,5-羟色胺和去甲肾上腺素转运蛋白上未发现活性。这些结果表明LE300用于可卡因成瘾治疗。使用体内测试发现了高活性:LE300抑制了自发运动能力,ID(50)为1.24 mg / kg,减弱了20 mg / kg可卡因诱导的运动能力,AD(50)为1.50 mg / kg。它不能替代可卡因产生的歧视性刺激作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号